showed a trendp = 0.028
Analyzing the number of eyes with glaucoma conversion or progression, eyes with systemic statin therapy for a time range of >10 years showed a trend towards a lower conversion and progression rate compared to a statin therapy of ≤10 years ( p = 0.028, Chi-Quadrat test, non-significant after Bonferroni–Holm; Figure 2 ). 3.2.